- Home
- ALEC vs CODA Comparison
ALEC vs CODA Comparison
Compare ALEC & CODA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALEC | CODA |
|---|---|---|
| Founded | 2013 | 1994 |
| Country | United States | United States |
| Employees | 103 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 158.8M | 134.4M |
| IPO Year | 2019 | 2007 |
Fundamental Metrics
Financial Performance| Metric | ALEC | CODA |
|---|---|---|
| Price | $1.54 | $10.18 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $4.83 | N/A |
| AVG Volume (30 Days) | ★ 879.4K | 148.8K |
| Earning Date | 05-04-2026 | 06-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.62 |
| EPS | N/A | ★ 0.23 |
| Revenue | ★ $21,045,000.00 | $20,316,161.00 |
| Revenue This Year | $2.03 | $18.28 |
| Revenue Next Year | $29.87 | $12.62 |
| P/E Ratio | ★ N/A | $43.48 |
| Revenue Growth | N/A | ★ 4.98 |
| 52 Week Low | $1.09 | $7.01 |
| 52 Week High | $3.40 | $18.00 |
Technical Indicators
Market Signals| Indicator | ALEC | CODA |
|---|---|---|
| Relative Strength Index (RSI) | 40.32 | 51.24 |
| Support Level | $1.37 | $8.94 |
| Resistance Level | $1.60 | $10.54 |
| Average True Range (ATR) | 0.14 | 0.35 |
| MACD | -0.03 | 0.14 |
| Stochastic Oscillator | 18.71 | 77.61 |
Price Performance
Historical ComparisonAbout ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
About CODA Coda Octopus Group Inc.
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company operates in three distinct business segments: the Marine Technology business, Acoustic Sensors and Material Business and the Defense Engineering Services Business. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.